Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor

Edwin N Neumann,Tessa M Bertozzi,Elaine Wu,Fiona Serack,John W Harvey,Pamela P Brauer,Catherine P Pirtle,Alissa Coffey,Michael Howard,Nikita Kamath,Kenney Lenz,Kenia Guzman,Michael H Raymond,Ahmad S Khalil,Benjamin E Deverman,Eric Vallabh Minikel,Sonia M Vallabh,Jonathan S Weissman
DOI: https://doi.org/10.1126/science.ado7082
IF: 56.9
2024-06-28
Science
Abstract:Prion disease is caused by misfolding of the prion protein (PrP) into pathogenic self-propagating conformations, leading to rapid-onset dementia and death. However, elimination of endogenous PrP halts prion disease progression. In this study, we describe Coupled Histone tail for Autoinhibition Release of Methyltransferase (CHARM), a compact, enzyme-free epigenetic editor capable of silencing transcription through programmable DNA methylation. Using a histone H3 tail-Dnmt3l fusion, CHARM recruits and activates endogenous DNA methyltransferases, thereby reducing transgene size and cytotoxicity. When delivered to the mouse brain by systemic injection of adeno-associated virus (AAV), Prnp-targeted CHARM ablates PrP expression across the brain. Furthermore, we have temporally limited editor expression by implementing a kinetically tuned self-silencing approach. CHARM potentially represents a broadly applicable strategy to suppress pathogenic proteins, including those implicated in other neurodegenerative diseases.
What problem does this paper attempt to address?